STUDIES AND REPORTS
APMGR represents its members’ viewpoint on the generic medicine industry from Romania and its regulatory framework. In this respect, APMGR wants to promote and support the development of the generic medicine industry in a very competitive environment.
The main objective of the member companies is to provide suitable medicines to Romanian patients at the right moment, in order to improve the quality of life.
In developing its activity APMGR is in permanent dialogue with national and European authorities, at the parliament and governmental level.
Ce este nevoie sa stiu despre Medicamentele Biosimilare – Informatii pentru pacienti
2016/2017
COMISIA EUROPEANA
The role of generic medicines in sustaining healthcare systems: a European perspective
16 June 2015
REPORT IMS HEALTH
Clawback Tax: how to apply and what is the impact on the producers of generic medicines
10 March 2015
INFOGRAPHIC
Clawback tax blocks access to treatment for thousands of patients, increases health expenditure by the disappearance of available drugs and destroy local pharmaceutical industry
10 July 2014
PRESENTATION
The European Biosimilars Group calls upon national authorities and medical societies to actively engage in reducing the knowledge gap about biosimilar medicines
3 April 2014
EGA PRESS RELEASE
EGA calls for single market measures to remove barriers to generic medicines
27 March 2014
EGA PRESS RELEASE
Remove barriers to competition & free trade to boost the generic medicines industry
19 March 2014
EGA PRESS RELEASE
PROTOCOL OF COOPERATION on Medicine Counterfeiting between APMGR, producers and distributors of medicines and public authorities
18 March 2014
PROTOCOL OF COOPERATION
EGA’S NEW VISION FOR THE GENERICE MEDICINES INDUSTRY , based on 5 pillars structure.
February 2014
The Conclusions of the European Union Council’s Working Party on Public Health: „Reflection process: Towards modern, responsive and sustainable health systems”
December 2013
WHITE PAPER ON THE BENEFITS BROUGHT BY GENERIC MEDICINES: social and economic perspectives
September 2013
PROTOCOL OF COOPERATION between the Ministry of Health and APMGR on increasing access to pharmaceutical treatment for Romanian patients, while allowing efficient public spending and encouraging the development of the local pharmaceutical industry
30 April 2013
PROTOCOL OF COOPERATION
Industrial policy: making Europe a hub for manufacturing of generic and biosimilar medicines
January 2013
EGA REPORT
THE ROMANIAN GENERIC MEDICINE INDUSTRY – between regional development and survival on the local market
25 September 2012
INNOVATION PARADIGM IN PHARMACY INDUSTRY
24 April 2012
APMGR PROPOSALS on regulating in Framework Agreement 2012 for medicine prescription as well as on Trade Name (DC) as International Joint Name (DCI) in the purpose of increasing population access to medicine and stimulate generic pharma industry.
8 April 2012
APMGR PROPOSALS on health system improvement.
5 March 2012
EFFECTS OF NEW CONTRIBUTION TO FINANCE SOME EXPENSES IN HEALTH (CLAW BACK TAX )
5 March 2012
APMGR PROPOSALS on improving the quality of legislative and administrative frame in health and increasing population access to medicine , as well as encouraging the local pharma industry
14 December 2011